MedTrace Logo

Epidemiological and Clinical-pathological Factors of Philadelphia-negative Myeloproliferative Neoplasms in Ecuador

NCT05825326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-04-27

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the epidemiological and clinical-pathological features of Philadelphia-negative myeloproliferative neoplasms through data from medical records

Conditions

  • Myeloproliferative Neoplasm
  • Myeloproliferative Syndrome
  • Myeloproliferative Neoplasm, Unclassifiable
  • Myeloproliferative Disorders
  • Myeloproliferative Disease, Not Classified

Sponsors & Collaborators

  • Sociedad de Lucha Contra el Cáncer del Ecuador

    lead OTHER

Principal Investigators

  • Fuad Huamán Garaicoa, MD · Sociedad de Lucha Contra el Cáncer del Ecuador

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05825326 on ClinicalTrials.gov